Instituto Universitario de Investigación en Neuroquímica
Centro/Instituto
![Foto de Instituto Universitario de Investigación en Neuroquímica](/img/uploaded/210288F0EBF11B5B400384EE1F7A6332.jpg)
![Foto de University of Connecticut](/img/noimage_org.png)
University of Connecticut
Storrs, Estados UnidosPublicaciones en colaboración con investigadores/as de University of Connecticut (8)
2022
2021
-
Non-ionic surfactant vesicles as novel delivery systems for sulfasalazine: Evaluation of the physicochemical and cytotoxic properties
Journal of Molecular Structure, Vol. 1230
2003
-
Compounds acting at the endocannabinoid and/or endovanilloid systems reduce hyperkinesia in a rat model of Huntington's disease
Journal of Neurochemistry, Vol. 84, Núm. 5, pp. 1097-1109
1999
-
Cannabinoid receptor and WIN-55,212-2-stimulated [35S]GTPγS binding and cannabinoid receptor mRNA levels in several brain structures of adult male rats chronically exposed to R-methanandamide
Neurochemistry International, Vol. 34, Núm. 6, pp. 473-482
-
Extrapyramidal and neuroendocrine effects of AM404, an inhibitor of the carrier-mediated transport of anandamide
Life Sciences, Vol. 65, Núm. 3, pp. 327-336
1998
-
Effects of cannabinoids on prolactin and gonadotrophin secretion: Involvement of changes in hypothalamic γ-aminobutyric acid (GABA) inputs
Biochemical Pharmacology, Vol. 56, Núm. 10, pp. 1331-1338
1997
-
Time course of the effects of different cannabimimetics on prolactin and gonadotrophin secretion: Evidence for the presence of CB 1 receptors in hypothalamic structures and their involvement in the effects of cannabimimetics
Biochemical Pharmacology, Vol. 53, Núm. 12, pp. 1919-1927
1996
-
Extrapyramidal effects of methanandamide, an analog of anandamide, the endogenous CB1 receptor ligand
Life Sciences, Vol. 58, Núm. 15, pp. 1249-1257